Actinomycin D
RxNorm 3100· ATC L01DA01· dactinomycin
KR · 한국Produkte in Korea (9)
- 유영닥티노마이신주(닥티노마이신)(주)유영제약
- 유영닥티노마이신주(닥티노마이신)(주)유영제약
- 유영닥티노마이신주(닥티노마이신)(주)유영제약
- 닥티노주사(닥티노마이신)(주)휴온스
- 닥티노주사(닥티노마이신)(주)휴온스
- 디티엠주(닥티노마이신)(수출용)[수출명:닥토신주(DactocinInj.)]대한뉴팜(주)
- 디티엠주(닥티노마이신)(수출용)[수출명:닥토신주(DactocinInj.)]대한뉴팜(주)
- 코스메겐주(닥티노마이신)한국메나리니(주)
- 코스메겐주(닥티노마이신)한국메나리니(주)
U.S. drug label (openFDA)
DACTINOMYCIN — indications, dosage, warnings, adverse events →Chemie (PubChem)
- Summenformel
- C62H86N12O16
- Molekülmasse
- 1255.4 g/mol
- IUPAC-Name
- 2-amino-4,6-dimethyl-3-oxo-1-N,9-N-bis[(3R,6S,7R,10S,16S)-7,11,14-trimethyl-2,5,9,12,15-pentaoxo-3,10-di(propan-2-yl)-8-oxa-1,4,11,14-tetrazabicyclo[14.3.0]nonadecan-6-yl]phenoxazine-1,9-dicarboxamide
- InChIKey
- RJURFGZVJUQBHK-IIXSONLDSA-N